Enfusion Inc Stock Price, News & Analysis

Enfusion, a provider of cloud-native software-as-a-service solutions for investment managers, will report its second quarter fiscal year 2022 financial results on August 9, 2022, after U.S. market close. A conference call will follow at 2:00 PM PT / 5:00 PM ET to discuss results and provide financial guidance. Enfusion's platform integrates front-, middle-, and back-office teams, serving over 750 investment managers globally from ten offices. A live webcast of the call will be available on their investor relations website.

DataArt has secured a $75 million minority growth investment from FTV Capital, marking a significant milestone following its record revenue growth in 2021, which exceeded $290 million. This funding aims to enhance DataArt's global delivery capabilities and innovate in cloud and data software services. Despite the geopolitical risks, the firm demonstrated resilience by hiring over 870 new employees in 2022 and relocating 1,300 staff due to the Ukraine conflict, ensuring uninterrupted service delivery.

Zoovu, an AI-driven e-commerce platform, has secured $169 million in funding led by FTV Capital. This investment aims to enhance Zoovu's market strategy and data-driven product platform primarily in the U.S., addressing the increasing demand for seamless online shopping experiences. As e-commerce grows, with 20% of retail sales attributed to online purchases, Zoovu’s solutions seek to minimize customer confusion and boost conversion rates for brands such as 3M and Microsoft. The company reported 85% growth in 2020 and 70% growth in 2021.

Enfusion, Inc. (NYSE: ENFN) has announced over 100 enhancements to its Order and Execution Management System (OEMS) in Q1 2022, reflecting a growing demand for SaaS-based solutions among asset managers facing market volatility and fee compression. Notably, OEMS bookings surged to 46% of total bookings, up from 25% year-on-year. Key upgrades include expanded fixed income support, improved broker defaults, and enhanced order functionalities for IRS and CDX. These enhancements aim to optimize operations for investment managers, making the platform suitable for a broader array of asset management strategies.

FTV Capital has appointed Kapil Venkatachalam as partner, focusing on investments in B2B software and technology-enabled services. This move follows FTV's successful close of a $2.3 billion fund in March 2022. With over 15 years at TCV, Kapil’s expertise aims to enhance FTV's investment strategy amidst growing demand for innovative solutions. FTV Capital, founded in 1998, has raised $6.2 billion and invested in over 130 companies, including Enfusion (NYSE: ENFN) and Globant (NYSE: GLOB).

Enfusion, Inc. (NYSE: ENFN) reported a 40% year-over-year revenue increase for Q1 2022, reaching $34.1 million, driven by strong client demand. The company added 42 new clients, achieving record contract values, including two seven-figure deals. However, the net income was $(12.5) million, influenced by $12.7 million in stock-based compensation. Total Annual Recurring Revenue (ARR) increased to $137.6 million, a 37% rise from the previous year. The company anticipates Q2 2022 revenues between $35 million and $36 million, with full-year guidance of $148.1 million to $151.1 million.

Northern Trust and Enfusion have established a partnership to enhance operational efficiency for mutual clients by integrating their services. This collaboration aims to streamline portfolio management, order execution, and analytics, providing an end-to-end solution for asset managers and hedge funds. Enfusion’s cloud-native platform removes operational barriers, enabling seamless data access across front, middle, and back offices. The partnership also includes a certified interface co-developed with Equity Data Science, demonstrating a commitment to delivering innovative financial services.

Enfusion, Inc. (NYSE: ENFN), a leading provider of cloud-native investment management software, announced participation in key investor events. CEO Thomas Kim and CFO Steve Dorton will represent Enfusion at the 42nd Annual Growth Stock Conference on June 6, 2022, the Bank of America Global Technology Conference on June 8, 2022, and the Morgan Stanley US Financials, Payments & CRE Conference on June 13, 2022. Enfusion aims to enhance data-driven intelligence across investment management through its software platform, serving over 730 investment managers globally.

Enfusion, a leader in cloud-native investment management software, will release its Q1 fiscal year 2022 financial results on May 12, 2022, after U.S. markets close. Following this, the company will conduct a conference call at 2:00 PM PT (5:00 PM ET) to discuss results and provide financial guidance. The call can be accessed via specific dial-in numbers, and a live webcast will also be available on Enfusion's Investor Relations page.